{"id":17868,"date":"2026-05-15T14:18:42","date_gmt":"2026-05-15T06:18:42","guid":{"rendered":"https:\/\/y2nbc5qg9c-staging.wpdns.site\/the-first-patent-for-amniotic-fluid-stem-cells-targeting-tens-of-billions-of-impotence-wealth-chairman-yong-lirong-those-who-are-dissatisfied-with-viagra-are-all-our-customers\/"},"modified":"2026-10-22T15:28:29","modified_gmt":"2026-10-22T07:28:29","slug":"the-first-patent-for-amniotic-fluid-stem-cells-targeting-tens-of-billions-of-impotence-wealth-chairman-yong-lirong-those-who-are-dissatisfied-with-viagra-are-all-our-customers","status":"publish","type":"post","link":"https:\/\/u-neuron.com\/en\/the-first-patent-for-amniotic-fluid-stem-cells-targeting-tens-of-billions-of-impotence-wealth-chairman-yong-lirong-those-who-are-dissatisfied-with-viagra-are-all-our-customers\/","title":{"rendered":"Pioneering Patented Amniotic Fluid Stem Cell Technology! Targeting a Multi-Billion-Dollar Market, U-NEURON Chairman States: &#8220;Anyone Dissatisfied with Viagra Is Our Customer&#8221;"},"content":{"rendered":"&#13;\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"2400\" height=\"1601\" class=\"wp-image-17344\" src=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400.webp\" alt=\"U-NEURON (6973) leverages its world-leading patented amniotic fluid stem cell technology to address the multi-billion-dollar blue ocean market of male erectile dysfunction (ED).&#010;According to statistics from the Taiwan Urological Association, approximately 1.7 million men over the age of 40 in Taiwan experience erectile dysfunction (ED).\" title=\"\" srcset=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400.webp 2400w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400-400x267.webp 400w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400-1199x800.webp 1199w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400-768x512.webp 768w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400-1536x1025.webp 1536w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400-2048x1366.webp 2048w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400-430x287.webp 430w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400-700x467.webp 700w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/a1572d8d-c134-41c7-86a7-905d2c60b6d4-w2400-150x100.webp 150w\" sizes=\"auto, (max-width: 2400px) 100vw, 2400px\" \/><\/figure>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Capitalizing on this massive market demand, U-NEURON (Stock Code: 6973)\u2014the first company in Taiwan to hold patents for amniotic fluid stem cell culture technology\u2014is unlocking this multi-billion-dollar market by advancing clinical research for its stem cell and exosome drug pipeline (Engine A).<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">\u00a0<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">U-NEURON Chairman Dr.\nFrank Chien emphasized that existing therapies, such as Viagra, fail to reverse underlying neural damage.\nIn contrast, U-NEURON\u2019s proprietary amniotic fluid stem cell candidate, &#8220;UA002,&#8221; is designed to repair damaged tissues and nerves.\nDr.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Chien confidently noted: &#8220;Anyone dissatisfied with Viagra is a potential customer for us.&#8221;\nU-NEURON is the first company globally to obtain a U.S.\npatent for amniotic fluid stem cell isolation and culture technology, and stands as the only biotech company in Asia utilizing amniotic fluid stem cells as its core R&amp;D driver.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Chairman Dr.\nFrank Chien stated that U-NEURON has long been deeply rooted in regenerative medicine, accumulating an extensive patent portfolio in amniotic fluid stem cells and exosomes.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">\u00a0<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Building on this proprietary R&amp;D platform, the company has established a diversified product pipeline spanning novel therapeutics, cosmeceuticals, and functional health foods.\nAccording to a report by Precedence Research, the global ED therapeutics market is projected to expand at a compound annual growth rate (CAGR) of 8.69% from 2025 to 2034, reaching approximately $6.74 billion by 2034.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">When combined with the sexual health supplement market, the total addressable male ED market exceedsUS$10billion.\nWhile the global ED market is vast, existing oral medications (such as Viagra) merely offer short-term symptom relief via temporary vasodilation.\nThese treatments carry potential cardiovascular risks and side effects, and cannot repair damaged nerves or blood vessels.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">U-NEURON\u2019s novel candidate UA002 aims to achieve fundamental tissue and neural restoration via a single intracavernosal injection, offering the potential for a curative solution.\nU-NEURON Chairman Dr.\nFrank Chien (center) previously served in the semiconductor industry.\nHe forms the company&#8217;s core leadership triad alongside President Dr.\nHsiao-Min Huang (left) and Vice President &amp; COO Shin-Yi Chuang (right).\nUA002 will be administered via localized injections at the base of the penis, requiring only 1 to 2 doses per year.<\/p>&#13;\n&#13;\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1600\" height=\"1200\" class=\"wp-image-17345\" src=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1.webp\" alt=\"20260325bus001\" title=\"\" srcset=\"https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1.webp 1600w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1-400x300.webp 400w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1-1067x800.webp 1067w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1-768x576.webp 768w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1-1536x1152.webp 1536w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1-430x323.webp 430w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1-700x525.webp 700w, https:\/\/u-neuron.com\/wp-content\/uploads\/2026\/05\/628b4dd7-50d7-4d75-b78e-0be422ef8f7d-w1600-1-150x113.webp 150w\" sizes=\"auto, (max-width: 1600px) 100vw, 1600px\" \/>&#13;\n<figcaption class=\"wp-element-caption\">Dr.\nChien estimates that its pricing will be approximately ten times that of Viagra.<\/figcaption>&#13;\n<\/figure>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">In addition to its therapeutic pipeline, U-NEURON leverages its proprietary technologies for high-end medical aesthetics, skincare, and functional nutraceuticals.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Through a strategic partnership with major shareholder Chlitina Holding Limited (4137), U-NEURON\u2019s products have successfully entered direct sales networks and major domestic e-commerce platforms, driving stable operational momentum.\nDrawing from his extensive semiconductor design and manufacturing background, Dr.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">Chien introduced the &#8220;i-ExoCraft\u00ae Intelligent Exosome Design &amp; Manufacturing Platform,&#8221; ushering the exosome industry into a new era modeled on the &#8220;Design House \u00d7 Foundry&#8221; paradigm.\nDriven by the dual-engine business model combining exosome therapeutics with cosmeceuticals and functional foods, U-NEURON has effectively overcome the traditional challenge of long development cycles faced by conventional drug developers, achieving exponential revenue growth in 2025.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\">As stem cell and exosome technologies accelerate commercial implementation and expand brand partnerships, institutional investors project that company revenues will continue to double in 2026.<\/p>&#13;\n&#13;\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.mirrormedia.mg\/story\/20260325bus001\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.mirrormedia.mg\/story\/20260325bus001<\/a><\/p>&#13;\n","protected":false},"excerpt":{"rendered":"<p>U-NEURON (6973) leverages its world-leading patented amniotic fluid stem cell technology to address the multi-billion-dollar blue ocean market of male erectile dysfunction (ED).<\/p>\n","protected":false},"author":15,"featured_media":17869,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[235,236,237],"tags":[],"class_list":["post-17868","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investor-zone","category-media-reports","category-new-drug-development-and-regulation"],"acf":[],"_links":{"self":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/posts\/17868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/comments?post=17868"}],"version-history":[{"count":11,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/posts\/17868\/revisions"}],"predecessor-version":[{"id":18378,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/posts\/17868\/revisions\/18378"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/media\/17869"}],"wp:attachment":[{"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/media?parent=17868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/categories?post=17868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/u-neuron.com\/en\/wp-json\/wp\/v2\/tags?post=17868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}